Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients
Abstract
Revascularisation is the gold standard therapy for patients with critical limb ischaemia (CLI). In over 30% of patients who are not suitable for or have failed previous revascularisation therapy (the 'no-option' CLI patients), limb amputation is eventually unavoidable. Preliminary studies have reported encouraging outcomes with autologous cell-based therapy for the treatment of CLI in these 'no-option' patients. However, studies comparing the...
Paper Details
Title
Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients
Published Date
Aug 29, 2018
Journal
Volume
2018
Issue
8
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History